1. 席霖枫#,张竹,谢万木,翟振国*.静脉血栓栓塞症年度进展2022.中华结核和呼吸杂志.2023.46(2) .187-191.核心期刊 |
2. Zhen KY#, Dong F#, Fang F, Gao Q, Zhang Z, Xia L, Wang W, Yang PR, Jia CB*, Liu P, Zhai ZG*, Wang C.Evaluation of In-Hospital Venous Thromboembolism Prevention and Management System Using Hospital-Level Metrics: A Nationwide Cross-Sectional Survey in China.J Patient Saf.2022.18(3).e626-e632.SCI |
3. 徐菲亚#, 翟振国*.静脉血栓栓塞领域年度进展2021.中华结核和呼吸杂志.2022.45(6) .588-592.核心期刊 |
4. Zhang S#, Xu XM#, Ji YQ#, Yang YH#, Yi Q#, Chen H#, Hu XY#, Liu ZH#, Mao YM#, Zhang J, Shi JH, Lei JP, Wang DY, Zhang Z, Wu SN, Gao Q, Tao XC, Xie WM, Wan J, Zhang YX, Zhang M, Shao X, Zhang ZH, Fang BM, Yang PR, Zhai ZG*, Wang C*.Clinical Phenotypes With Prognostic Implications in Pulmonary Embolism Patients With Syncope.Front Cardiovasc Med.2022.9.836850.SCI |
5. Jixiang Liu#, Peiran Yang, Han Tian, Kaiyuan Zhen, Colm McCabe8, Lan Zhao8, Zhenguo Zhai*.Right Ventricle Remodeling in Chronic Thromboembolic Pulmonary Hypertension.J Transl Int Med .2022.10(2).125-133.SCI |
6. 王丁一#,范国辉,吴司南,翟振国*.肾功能不全与静脉血栓栓塞症.中华结核和呼吸杂志.2022.45(02).204-208.核心期刊 |
7. Ziyi Chang#, Jixiang Liu#, Bei Wang, Honglei Zhang, Ling Zhao, Yunchao Su, Wanmu Xie, Qiang Huang, Yanan Zhen, Fan Lin, Min Liu, Qian Gao, Wenyi Pang, Zhu Zhang, Han Tian, Yishan Li, Peiran Yang, Zhenguo Zhai*, Dingrong Zhong*.Clinicopathological Correlation of Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study.J Clin Med .2022.11(22).6659.SCI |
8. Pang WY#, Zhang Z, Zhang YX, Zhang M, Miao R, Yang YH, Xie WM, Wan J, Zhai ZG*, Wang C.Extracellular matrix collagen biomarkers levels in patients with chronic thromboembolic pulmonary hypertension.J Thromb Thrombolysis.2021.52(1).48-58.SCI |
9. Ma RZ#, Han PP, Tao XC, Li H, Wang L, Zhai ZG*, Fu LP*.A Feasibility Study on Using Single-Photon Emission Computed Tomography Pulmonary Perfusion/Ventilation Imaging for the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension and Patient Risk Assessment. Int J Gen Med.2021.14.8029-8038.SCI |
10. 中华医学会呼吸病学分会肺栓塞与肺血 管病学组,中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会,全国肺栓塞与肺血管病防治协作组,全国肺动脉高压标 准化体系建设项目专家组,翟振国*,王辰*.中国肺动脉高压诊断与治疗指南(2021版).中华医学杂志.2021.101(1).11-51.核心期刊 |
11. Zhang S#, Wang J, Qi XM, Tao XC, Xie WM, Wan J, Shen YH, Zhai ZG*.Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.Exp Cell Res.2021.398(1).112392.SCI |
12. Pang WY#, Zhang Z#, Wang ZH, Zhen KY, Zhang M, Zhang YX, Gao Q, Zhang S, Tao XC, Wan J, Xie WM*, Zhai ZG*..Higher Incidence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism in Asians Than in Europeans: A Meta-Analysis. Front Med (Lausanne).Front Med (Lausanne).2021.8.721294.SCI |
13. Zhai ZG#*, Wang DY#, Lei JP#, Yang YH#, Xu XM#, Ji YQ#, Yi Q#, Chen H#, Hu XY#, Liu ZH#, Mao YM#, Zhang J, Shi JH, Zhang Z#, Wu SN, Gao Q, Tao XC, Xie WM, Wan J, Zhang YX, Zhang S, Zhen KY, Zhang ZH, Fang BM, Wang C*.Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: an analysis from the China pUlmonary thromboembolism REgistry Study (CURES).Eur Respir J.2021.58(4).2002963.SCI |
14. Qin W#, Chen S#, Zhang YX#, Dong F#, Zhang Z#, Hu BZ, Zhu ZY, Li FJ, Wang XJ, Wang YM, Zhen KY, Wang J, Wan YL, Li HB, Elalamy I, Li CH*, Zhai ZG*, Wang C.Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up.Eur Respir J.2021.58(1).2003677.SCI |
15. Qin W#, Dong F#, Zhang Z#, Hu B#, Chen S#, Zhu ZY, Li FJ, Wang XJ, Zhang YX, Wang YM, Zhen KY, Wang J, Elalamy I, Li CH*, Zhai ZG*, Davidson BL, Wang C.Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era.Thromb Res.2021.198.19-22.SCI |
16. Dong F#, Zhen KY#, Zhang Z, Si CZ, Xia JF, Zhang TS, Xia L, Wang W, Jia CB, Shan GJ, Zhai ZG*, Wang C.Effect on thromboprophylaxis among hospitalized patients using a system-wide multifaceted quality improvement intervention: Rationale and design for a multicenter cluster randomized clinical trial in China. Am Heart J.Am Heart J.2020.225.44-54.SCI |
17. Wang DY#, Shao X, Lei JP, Zhai ZG*.A survey of precision diagnosis and management capacity of pulmonary embolism in 90 hospitals of China. Clin Respir J.2020.14(7).638-644.SCI |
18. Zhang YX#, Zhang M#, Xie WM, Wan J, Tao XC, Liu M, Zhen YN, Lin F, Wu B, Zhai ZG*, Wang C*.Gremlin-1 is a key regulator of endothelial-to-mesenchymal transition in human pulmonary artery endothelial cells.Exp Cell Res.2020.390(1).111941.SCI |
19. Zhai ZG#, Li CH#, Chen YL#, Gerotziafas G, Zhang ZL, Wan J, Liu P, Elalamy I#*, Wang C*.Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.Thromb Haemost.2020.120(6).937-948.SCI |
20. Wang DY#, Fan GH, Liu X, Wu SN*, Zhai ZG*.Renal Insufficiency and Short-Term Outcomes of Acute Pulmonary Embolism: A Systemic Review and Meta-Analysis. Thromb Haemost.Thromb Haemost.2020.120(7).1025-1034.SCI |
21. Li CH#, Hu BZ#, Zhang Z#, Qin W#, Zhu ZY, Zhai ZG*, Davidson BL*, Wang C.D-dimer Triage for COVID-19.Acad Emerg Med.2020.27(7).612-613.SCI |
22. Lei JP#, Xu XM#, Ji YQ#, Yang YH#, Yi Q#, Chen H#, Hu XY#, Liu ZH#, Mao YM#, Zhang J, Shi JH, Wang DY#, Zhang S, Zhang Z, Wu SN, Gao Q, Tao XC, Xie WM, Wan J, Zhang YX, Zhang M, Shao X, Zhang ZH, Fang BM, Zhai ZG*, Wang C*, China pUlmonary Thromboembolism REgistry Study (CURES) investigators.Rational and design of the China Pulmonary Thromboembolism Registry Study (CURES): A prospective multicenter registry.Int J Cardiol.2020.316.242-248.SCI |
23. Zhang Z#, Lei J#, Zhai Z*, Yang Y, Wan J, Xie W, Wang C*..Comparison of prediction value of four bleeding risk scores for pulmonary embolism with anticoagulation: a real-world study in Chinese patients.Clin Respir J.2019.13(3).139-147.SCI |
24. Zhang M#, Zhang YX#, Zhang Z, Wang J, Shao X, Xie WM, Wan J, Zhai ZG*, Wang C*..Awareness and management of pulmonary embolism among physicians in China: a nationwide cross-sectional study..Journal of Thrombosis and Thrombolysis.2019.47(3).436-443.SCI |
25. Zhai ZZ#, Kan QC, Li WM, Qin XY, Qu JM, Shi YK, Xu YM, Zhang Z#, Wang C*.VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study..Chest.2019.155(1).114-122.SCI |
26. Zhang Z#, Lei JP, Shao X, Dong F, Wang J, Wang DY, Wu SN, Xie WM, Wan J, Chen H, Ji YQ, Yi Q, Xu XM, Yang YH, Zhai ZG*, Wang C*.China Venous Thromboembolism Study Group. Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in China.Chest.2019.155(2).342-353.SCI |
27. 中华医学会呼吸病学分会肺栓塞与肺血管病学组,中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会,全国肺栓塞与肺血管病防治协作组.王辰*,翟振国*.肺血栓栓塞症诊治与预防指南.中华医学杂志.2018.98(14).1060-1087.核心期刊 |
28. Zou L, Li W, Han J, Yang Y, Jin J, Xiao F, Xu X, Zhai Z*,.Identification of a low frequency missense mutation in MUC6 contributing to pulmonary artery hypertension by whole-exome sequencing.Pulmonary Circulation,.2018.8(3).1-8.SCI |
29. Chen X, Zhai Z*, Huang K, Xie W, Wan J, Wang C..Bosentan Therapy for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: A Systemic Review and Meta-Analysis.Clin Respir J.2018.12(6).2065-2074.SCI |
30. Zou LH#, Zhang JH#, Han JL, Li WQ, Su F, Xu XM, Zhai ZG*, Xiao F*.cGMP interacts with tropomyosin and downregulates actin-tropomyosin-myosin complex interaction.Respir Res.2018.19(1).201.SCI |
31. Zhang Y, Li J, Yang Y, Huang K, Miao R, Zhai Z*, Wang C*..Identification of haptoglobin as a potential diagnostic biomarker of acute pulmonary embolism..Blood Coagulation and Fibrinolysis.2018.29(3).275-281.SCI |
32. Zhang Z, Zhai Z*, Yang Y, Wan J, Xie W, Zhu J, Shen YH, Wang C..Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a“real-world” study..Journal of Thrombosis and Thrombolysis.2017.43(4).540-549.SCI |
33. 朱妍妍,邝土光*,翟振国*,杨媛华,谢万木.不同强度华法林抗凝治疗对肺血栓栓塞症二级预防预后及凝血功能的影响研究.中国实用内科杂志.2017.37(12).1099-1101. |
34. 周霞,石慧,马瑞晓,翟振国*.动脉性肺动脉高压和慢性血栓栓塞性肺动脉高压患者生活质量及其影响因素研究进展.中国实用内科杂志.2017.37(08).754-756.. |
35. Zhai Z#, Zhou X#, Zhang S#, Xie W, Wan J, Kuang T, Yang Y, Huang H, Wang C*..The impact and financial burden of pulmonary arterial hypertension on patients and caregivers: results from a national survey..Medicine.2017.96(39).e8165.SCI |
36. 翟振国,王丁一,王辰*.全面推进肺血栓栓塞症的精准医学研究.中华医学杂志.2017.(36).2803-2805.核心期刊 |
37. 周霞,石慧,马瑞晓,翟振国*.动脉性肺动脉高压和慢性血栓栓塞性肺动脉高压患者生活质量及其影响因素研究进展.中国实用内科杂志.2017.37(08).754-756.核心期刊 |
38. 门剑龙,翟振国*.血栓实验室检查的循证发展与挑战.中华检验医学杂志.2017.40(4).331-334.核心期刊 |
39. Zhou X, Zhang Z, Zhai Z*, Zhang Y, Miao R, Yang Y, Xie W, Wan J, Wang C..Pleural effusions as a predictive parameter for poor prognosis for patients with .Journal of Thrombosis and Thrombolysis.2016.42(3).432-40.SCI |
40. Zhang S#, Zhai Z#*, Yang Y#, Zhu J, Gong J, Xie W, Kuang T, Wang C*. .Long-term treatment with low-molecular-weight heparin prolonged the survival time for acute pulmonary embolism patients concurrent with malignancy: An observational analysis from a long-term follow-up study.Thrombosis Research.2015.135.582–587.SCI |
41. Li Y#, Wang Y#, Zhai Z#, Guo X, Wu Y, Yang Y, Lu X*.Relationship between echocardiographic and cardiac magnetic resonance imaging-derived measures of CTEPH.Thrombosis Research.2015.135(4).602-6.SCI |
42. Zhang Z, Zhai ZG*, Liang LR, Liu FF, Yang YH, Wang C. .Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: A systematic review and meta-analysis.Thrombosis Research.2014.133(23).357–363.SCI |
43. Li Y, Zhai Z#, Wu Y, Yang Y, Gu S, Liu Y, Su P, Wang C.Improvement of right ventricular dysfunction after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension.Thrombosis Research.2013.131(5).196-201.SCI |
44. Li YY, Zhai ZG*, Yang YH, Pang BS, Wang HY, Zhang W, Zhao L, Wang J, Wang C*..Association of the 894G>T polymorphism in the endothelial nitric oxide synthase.Thromb Res. .2011.127(4.324-327.SCI |
45. Zhai Z, Murphy K, Tighe H, Wang C, Wilkins MR, Gibbs JS, Howard LS*.Differences in ventilatory inefficiency between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Chest.2011.140(5).1284-1291.SCI |
46. Yang Y, Liang L, Zhai Z, He H, Xie W, Peng X, Wang C*; on behalf of investigators for the National Cooperative Project for the Prevention and Treatment of PTE-DVT. .Pulmonary Embolism Incidence and Fatality Trends in Chinese Hospitals from 1997 to 2008: A Multicenter Registration Study.PLoS One.2011.6(11).e26861.SCI |
47. Zhai Z, Zhan X, Yang Y, Wang C*..Recent research on venous thromboembolism in China: a brief report from China Venous Thromboembolism Study Group.Chinese Medical Journal.2010.123(4).485-490.SCI |
48. Wang C#*, Zhai Z#, Yang Y#, Wu Q, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH; China Venous Thromboembolism (VTE) Study Group..Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute .Chest.2010.137(2).254-262.SCI |
49. Zhai Z, Wang J, Zhao L, Yuan XJ, Wang C*.Pulmonary hypertension in China:Pulmonary Vascular Disease: The Global Perspective.Chest.2010.137.69S-77S.SCI |
50. Wang C#*, Zhai Z#, Yang Y#, Yuan Y, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH; China Venous Thromboembolism Study Group..Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial.Respiratory Research.2009.128.1-9.SCI |